Arsenal have helped fund Park Theatre’s Reminiscence Group for people with dementia. Stephen Whittle tells us about them ...

Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...

We asked Dr. Joanne Pike, CEO of the Alzheimer's Association to help explain the challenges and hopes when it comes to this debilitating disease.

Nov. 6, 2024 — Older people who are sleepy during the day or lack enthusiasm for activities due to sleep issues may be more likely to develop a syndrome that can lead to dementia, according to a new ...

According to the Alzheimer’s Society, depression in dementia may occur as people with AD find it more difficult to cope with symptoms of cognitive decline. For instance, as people with AD may ...

Heather Snyder discusses the Alzheimer's Association's research initiatives, breakthroughs in diagnostics, and the importance ...

Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ in rare pediatric disease HLHS has achieved more than 80% enrollmentPositive Type C ...

Fiona Carragher, chief policy and research officer at the Alzheimer's Society, said the decision by NICE was “disheartening,” but noted there were about 20 Alzheimer's drugs being tested in ...

At SfN 2024, neuroscientists converge to share groundbreaking research, fostering interdisciplinary connections and advancing ...

Alzheimer’s Society, the UK’s leading dementia charity, says changes to speech is one of six possible signs of dementia to be aware of for people concerned about themselves or a loved one.

When lecanemab was rejected in Nice’s draft guidance, the Alzheimer’s Society said families across the country had been left in “uncertainty and confusion”. Alzheimer’s Research UK said ...

It is estimated that men in the United States aged 65 years have a 19.5 percent chance of developing Alzheimer's disease during their lifetime, while the lifetime risk for women age 65 years is 21 ...